Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease
By M. Fraquelli, C. Rigamonti, G. Casazza, D. Conte, M. F. Donato, G. Ronchi, M. Colombo. Gut, 2007
898 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology
View Paper: https://www.semanticscholar.org/paper/861106fa346e4faab0f8e935f23cf825e1b9c058
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Asociacion Latinoamericana para el Estudio del Higado
- Laurent Castéra
- M. Kudo
- Christoph Sarrazin
- E. Tsochatzis
- A. Berzigotti
- X. Forns
In Hepatology
- Asociacion Latinoamericana para el Estudio del Higado
- Laurent Castéra
- M. Kudo
- Christoph Sarrazin
- Andrew K. Burroughs
- F. Piscaglia
- A. Berzigotti
- X. Forns
Citations in the corpus
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. (2011, background): “It is simple, highly reproducible, and can be completed in 10 min in an outpatient setting with no significant expertise [3].”
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017, background): “The agreement decreases in overweight patients or in early stages of fibrosis [94, 95].”
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, background): “TE has also been evaluated in a variety of chronic liver diseases [56,144,162], as well as in primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) [163,164], and ALD [151,165] (Table 6).”
- Non-invasive evaluation of liver fibrosis using transient elastography. (2008, background): “Two independent groups [14,25], recently addressed this issue with similar results.”
- WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, methodology): “TE has also been evaluated in cholestatic liver diseases (Corpechot et al. 2012, Corpechot et al. 2006b), in a variety of chronic liver diseases (Foucher et al. 2006a; Fraquelli et al. 2007; Ganne-Carrie et al. 2006) as well as in alcoholic liver disease (Nahon et al. 2008; Nguyen-Khac et al. 2008).”
- EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications (2013, neutral): “Intra-and inter-observer reproducibility of TE measurements are excellent (ICC 0.98 for both) in non-obese subjects [40].”
- Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. (2008, background): “Barreiro P Antiviral Therapy 2006 (6) x Non-invasive assessment of liver fibrosis after antiviral therapy in patients with SVR versus nonresponse Kelleher T J Hepatol 2006 (8) x”